Home » Stocks » Aptorum Group

Aptorum Group Limited (APM)

Stock Price: $3.52 USD -0.17 (-4.61%)
Updated Aug 11, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 106.97M
Revenue (ttm) 535,166
Net Income (ttm) -18.69M
Shares Out 7.95M
EPS (ttm) -0.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 11, 2020
Last Price $3.52
Previous Close $3.69
Change ($) -0.17
Change (%) -4.61%
Day's Open 3.66
Day's Range 3.49 - 3.68
Day's Volume 86,249
52-Week Range 1.66 - 18.26

More Stats

Market Cap 106.97M
Enterprise Value 106.88M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 7.95M
Float 4.73M
EPS (basic) -0.64
EPS (diluted) -0.64
FCF / Share -0.49
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 30,016
Short Ratio 0.19
Short % of Float 0.60%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 199.88
PB Ratio 6.59
Revenue 535,166
Operating Income -18.20M
Net Income -18.69M
Free Cash Flow -14.22M
Net Cash 86,797
Net Cash / Share 0.00
Gross Margin -48.47%
Operating Margin -3,400.52%
Profit Margin -3,491.80%
FCF Margin -2,657.06%
ROA -32.95%
ROE -84.53%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(269.32% upside)
Current: $3.52
Target: 13.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth39.57%-
Gross Profit-0.260.07
Operating Income-18.20-10.33
Net Income-18.69-14.83
Shares Outstanding29.0127.91
Earnings Per Share-0.64-0.53
Operating Cash Flow-13.38-10.04
Capital Expenditures-0.84-5.65
Free Cash Flow-14.22-15.68
Cash & Equivalents6.5627.24
Total Debt6.4710.30
Net Cash / Debt0.0916.94
Book Value16.3633.11
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Aptorum Group Limited
Country Hong Kong
Employees 36
CEO Ian Huen

Stock Information

Ticker Symbol APM
Stock Exchange NASDAQ
Unique Identifier NASDAQ: APM
IPO Date December 18, 2018


Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The company also focuses on the development of surgical robotics and medical devices; and operating outpatient clinic. Aptorum Group Limited has a research and development agreement with Covar Pharmaceuticals to investigate 3 repurposed drug candidates (SACT-COV19) for coronavirus disease under existing Smart-ACT platform and Acticule infectious disease platform. Aptorum Group Limited was incorporated in 2010 and is headquartered in Hong Kong, Hong Kong.